Birgit Morgenstern
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Infection Control in Healthcare
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 1
- Infection Control in Healthcare 1
- HIV/AIDS drug development and treatment 1
-
- interferon and immune responses 2
- Co-authors
- Gabriele Bauer (4 shared papers)Holger Felix Rabenau (4 shared papers)J Cinátl (2 shared papers)Doerr Hw (1 shared paper)Hans Wilhelm Doerr (3 shared papers)Jindrich Jr. Cinatl (4 shared papers)Wolfgang Preiser (2 shared papers)Martin Michaelis (3 shared papers)
- Journals
- The Lancet (2 papers)Journal of Clinical Virology (1 paper)Biochemical and Biophysical Research Communications (1 paper)International Journal of Molecular Medicine (1 paper)Medical Microbiology and Immunology (1 paper)
- Partner nations
- Germany
In The Last Decade
Birgit Morgenstern
8 papers receiving 2k citations
Birgit Morgenstern's Hit Papers
Peers
Comparison fields: 5 of 122
- Infectious Diseases 1.1k
- Pharmacology 196
- General Dentistry 9
- Complementary and alternative medicine 138
- Chemical Health and Safety 8
Countries citing papers authored by Birgit Morgenstern
This map shows the geographic impact of Birgit Morgenstern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Morgenstern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Morgenstern more than expected).
Fields of papers citing papers by Birgit Morgenstern
This network shows the impact of papers produced by Birgit Morgenstern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Morgenstern. The network helps show where Birgit Morgenstern may publish in the future.
Co-authors
The 16 scholars most cited alongside Birgit Morgenstern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Hit paper breakdown → | 2003 | 990 |
| 2 | 2004 | 434 | |
| 3 | 2003 | 391 | |
| 4 | 2004 | 186 | |
| 5 | 2004 | 69 | |
| 6 | 2005 | 29 | |
| 7 | Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. | 2005 | 9 |
| 8 | 2002 | 7 |
About Birgit Morgenstern
Birgit Morgenstern is a scholar working on Infectious Diseases, Immunology, Pharmacology, Oncology and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 2.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), interferon and immune responses (2 papers), Infection Control and Ventilation (1 paper), COVID-19 Clinical Research Studies (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Infection Control in Healthcare (1 paper), Chemokine receptors and signaling (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Infectious Diseases (1.1k citations), Pharmacology (196 citations), General Dentistry (9 citations), Complementary and alternative medicine (138 citations) and Chemical Health and Safety (8 citations). Birgit Morgenstern has collaborated with scholars based in Germany. Frequent co-authors include Gabriele Bauer, Holger Felix Rabenau, J Cinátl, Doerr Hw, Hans Wilhelm Doerr, Jindrich Jr. Cinatl, Wolfgang Preiser, Martin Michaelis, Hans Willhelm Doerr and Patrick C. Baer. Their work appears in journals such as The Lancet, Journal of Clinical Virology, Biochemical and Biophysical Research Communications, International Journal of Molecular Medicine and Medical Microbiology and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.